CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 20 | 23 | +3 |
| Shares | 1.73M | 1.23M | −499.6K (−28.8%) |
| Value | $589.0K | $343.5K | −$245.5K (−41.7%) |
New holders (7)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FSM Wealth Advisors, LLC | 40,000 | $10.0K | 0.01% |
| United Capital Financial Advisers, LLC | 18,944 | $5.00K | 0.00% |
| StoneX Group Inc. | 15,921 | $4.46K | 0.00% |
| Citigroup Inc | 13,400 | $4.00K | 0.00% |
| Millennium Management LLC | 10,384 | $3.00K | 0.00% |
| Prime Capital Investment Advisors, LLC | 10,727 | $3.00K | 0.00% |
| Urban Wealth Management, LLC | 100 | $0 | 0.00% |
Sold out (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Renaissance Technologies LLC | 506,532 | $173.0K |
| BlackRock Inc. | 41,087 | $14.0K |
| Beacon Financial Advisory LLC | 40,000 | $14.0K |
| Two Sigma Investments, LP | 25,143 | $9.00K |